Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Trastuzumab emtansine for HER2-positive advanced breast cancer.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Trastuzumab emtansine for HER2-positive advanced breast cancer.
Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med. 2012 Nov 08; 367(19):1783-91.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Deoxycytidine
Disease-Free Survival
Female
Fluorouracil
Humans
Intention to Treat Analysis
Kaplan-Meier Estimate
Maytansine
Middle Aged
Neoplasm Metastasis
Quinazolines
Receptor, erbB-2
Survival Rate
Young Adult